Posted by Michael Wonder on 12 Apr 2021
CBO report shows enacting drug pricing legislation will result in fewer new drugs
12 April 2021 - If there was a silver lining in the COVID-19 pandemic, it was the response of the biopharmaceutical industry in generating multiple new vaccines with unprecedented speed – vaccines that promise to bring a sense of normalcy to the world.
Social media is awash with selfies of people getting vaccinated (myself included!) universally expressing thanks to the science and scientists that helped to make this happen. Furthermore, it is not unusual to see people get emotional when getting their first shot after more than a year of masks, isolation and, most regrettably, the loss of loved ones.
The development of COVID-19 vaccines has been a stunning achievement.
